Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma

Karl Payne; Rachel Spruce; Andrew Beggs; Neil Sharma; Anthony Kong; Timothy Martin; Satyesh Parmar; Prav Praveen; Paul Nankivell; Hisham Mehanna

doi:10.1002/hed.25140

Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma

Karl Payne, Rachel Spruce, Andrew Beggs, Neil Sharma, Anthony Kong, Timothy Martin, Satyesh Parmar, Prav Praveen, Paul Nankivell, Hisham Mehanna

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

284 Downloads (Pure)

Abstract

The use of circulating biochemical molecular markers in head and neck cancer holds the promise of improved diagnostics, treatment planning, and posttreatment surveillance. In this review, we provide an introduction for the head and neck surgeon of the basic science, current evidence, and future applications of circulating tumor DNA (ctDNA) as a biomarker and liquid biopsy to detect tumor genetic heterogeneity in patients with head and neck squamous cell carcinoma (HNSCC).

Original language	English
Pages (from-to)	1598-1604
Number of pages	7
Journal	Head & Neck
Volume	40
Issue number	7
Early online date	15 Mar 2018
DOIs	https://doi.org/10.1002/hed.25140
Publication status	Published - 1 Jul 2018

Bibliographical note

Payne K, Spruce R, Beggs A, et al. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma. Head & Neck. 2018;40:1598–1604. https://doi.org/10.1002/hed.25140

Keywords

Journal Article
biomarker
circulating tumor DNA (ctDNA)
head and neck cancer
liquid biopsy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hed.25140Licence: Creative Commons: Attribution (CC BY)

Payne_et_al_Circulating_tumor_DNA_Head_&_Neck_2018
Published in Head & Neck on 15/03/2018 DOI: 10.1002/hed.25140
Final published version, 354 KBLicence: Creative Commons: Attribution (CC BY)

https://onlinelibrary.wiley.com/doi/full/10.1002/hed.25140Licence: Creative Commons: Attribution (CC BY)

Cite this

@article{ffc02cd32f9640b9a69ed2bb3867d4da,

title = "Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma",

abstract = "The use of circulating biochemical molecular markers in head and neck cancer holds the promise of improved diagnostics, treatment planning, and posttreatment surveillance. In this review, we provide an introduction for the head and neck surgeon of the basic science, current evidence, and future applications of circulating tumor DNA (ctDNA) as a biomarker and liquid biopsy to detect tumor genetic heterogeneity in patients with head and neck squamous cell carcinoma (HNSCC).",

keywords = "Journal Article, biomarker , circulating tumor DNA (ctDNA), head and neck cancer , liquid biopsy",

author = "Karl Payne and Rachel Spruce and Andrew Beggs and Neil Sharma and Anthony Kong and Timothy Martin and Satyesh Parmar and Prav Praveen and Paul Nankivell and Hisham Mehanna",

note = "Payne K, Spruce R, Beggs A, et al. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma. Head & Neck. 2018;40:1598–1604. https://doi.org/10.1002/hed.25140",

year = "2018",

month = jul,

day = "1",

doi = "10.1002/hed.25140",

language = "English",

volume = "40",

pages = "1598--1604",

journal = "Head & Neck",

issn = "1043-3074",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma

AU - Payne, Karl

AU - Spruce, Rachel

AU - Beggs, Andrew

AU - Sharma, Neil

AU - Kong, Anthony

AU - Martin, Timothy

AU - Parmar, Satyesh

AU - Praveen, Prav

AU - Nankivell, Paul

AU - Mehanna, Hisham

N1 - Payne K, Spruce R, Beggs A, et al. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma. Head & Neck. 2018;40:1598–1604. https://doi.org/10.1002/hed.25140

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The use of circulating biochemical molecular markers in head and neck cancer holds the promise of improved diagnostics, treatment planning, and posttreatment surveillance. In this review, we provide an introduction for the head and neck surgeon of the basic science, current evidence, and future applications of circulating tumor DNA (ctDNA) as a biomarker and liquid biopsy to detect tumor genetic heterogeneity in patients with head and neck squamous cell carcinoma (HNSCC).

AB - The use of circulating biochemical molecular markers in head and neck cancer holds the promise of improved diagnostics, treatment planning, and posttreatment surveillance. In this review, we provide an introduction for the head and neck surgeon of the basic science, current evidence, and future applications of circulating tumor DNA (ctDNA) as a biomarker and liquid biopsy to detect tumor genetic heterogeneity in patients with head and neck squamous cell carcinoma (HNSCC).

KW - Journal Article

KW - biomarker

KW - circulating tumor DNA (ctDNA)

KW - head and neck cancer

KW - liquid biopsy

U2 - 10.1002/hed.25140

DO - 10.1002/hed.25140

M3 - Article

C2 - 29542214

SN - 1043-3074

VL - 40

SP - 1598

EP - 1604

JO - Head & Neck

JF - Head & Neck

IS - 7

ER -

Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this